AHCL Anlon Healthcare Q1 FY27 results (Apr–Jun 2026) and concall
Anlon Healthcare Limited reported strong top-line and bottom-line growth in Q1 FY27, with total income surging by 163% YoY to ₹87.62 crores and PAT increasing by 133% YoY to ₹8.28 crores. This growth was significantly driven by recent acquisitions, particularly the 63.98% stake in Remember India Health links, marking the company's entry into finished dosage formulation. However, EBITDA margins moderated to 17% due to sharp raw material price increases and the initial investment phase of acquired entities, though management expects normalization to 25-30% by Q3 FY27.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q1 FY27: revenue up 162.9%, net profit up 133.2% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 24 | 9 | 49 | 33 | 52 +116% | 36 +280% | 51 +4% | 88 +163% |
| EBITDA | 8 | 1 | 17 | 6 | 14 +83% | 12 +2017% | 15 −11% | 16 +150% |
| Net profit | 3 | -2 | 17 | 4 | 9 +260% | 5 +307% | 11 −34% | 8 +133% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
